INVENTIVA (EPA:IVA) | WebDisclosure

PRESS RELEASE

published on 05/27/2025 at 22:00, 1 year 4 months ago

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
Inventiva participera à deux conférences investisseurs en juin 2025 : Jefferies Global Healthcare Conference et UBS Spring Biotech Conference. Présentation stratégique de la société et du médicament Lanifibranor

Conférences Investisseurs Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 1 year 4 months ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 1 year 5 months ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
BRIEF

published on 05/23/2025 at 08:35, 1 year 5 months ago

Inventiva publie ses résultats financiers du premier trimestre 2025 : la trésorerie diminue

Résultats Financiers Essai Clinique Situation De Trésorerie Inventiva Lanifibranor
PRESS RELEASE

published on 05/23/2025 at 08:30, 1 year 5 months ago

Inventiva reports 2025 First Quarter Financial Information¹
Inventiva reports €67.9 million in cash and cash equivalents for Q1 2025. Forecasted funds to support operations until Q3 2026. Key milestones include Phase 3 trial results expected in late 2026

Financial Information Inventiva Q1 2025 Cash Equivalents NATiV3 Trial
PRESS RELEASE

published on 05/23/2025 at 08:30, 1 year 5 months ago

Inventiva publie ses informations financières¹ du 1er trimestre 2025
Inventiva publie ses informations financières du 1er trimestre 2025, avec une trésorerie de 67,9 millions d'euros. Progrès notables en R&D et publications scientifiques récentes dévoilées

R&D Trésorerie Publications Scientifiques Inventiva Trimestre 2025
BRIEF

published on 05/22/2025 at 14:05, 1 year 5 months ago

Inventiva Unveils Details of Share Repurchase Program

Share Repurchase Liquidity Agreement Capital Reduction Market Stability Employee Stock Options
BRIEF

published on 05/22/2025 at 14:05, 1 year 5 months ago

Inventiva dévoile les détails de son programme de rachat d'actions

Rachat D'actions Réduction De Capital Stabilité Du Marché Accord De Liquidité Options D'achat D'actions Des Employés
PRESS RELEASE

published on 05/22/2025 at 14:00, 1 year 5 months ago

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
Inventiva implements share repurchase program with Kepler Chevreux under liquidity agreement approved by Ordinary General Meeting. Program details and objectives announced for 18-month period

Liquidity Agreement Ordinary General Meeting Share Repurchase Program Inventiva Kepler Chevreux
BRIEF

published on 05/15/2025 at 14:31, 1 year 5 months ago

Franchissements de seuils chez INVENTIVA

Capital Droits De Vote Augmentation De Capital Franchissement De Seuils Inventiva

Published on 10/26/2026 at 14:10, 4 hours 34 minutes ago

China XLX Announces 2026 9M Results
Published on 10/26/2026 at 13:30, 5 hours 14 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 5 hours 44 minutes ago

BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 13:00, 5 hours 44 minutes ago

GameSquare Closes FanEngine Transaction
Published on 10/26/2026 at 12:30, 6 hours 14 minutes ago

Longview Capital Announces Voluntary TSXV Delisting

View all ACCESSWIRE

Published on 10/26/2026 at 18:21, 23 minutes ago

EU RIS CSDS Toncoin Name Change (26 October 2026)
Published on 10/26/2026 at 17:59, 45 minutes ago

EQS-Adhoc: CANCOM SE publishes preliminary Q3 2026 figures and revises its revenue forecast for the 2026 financial year
Published on 10/26/2026 at 17:52, 51 minutes ago

Viromed Medical AG: Successful Completion of Capital Increase
Published on 10/26/2026 at 17:48, 56 minutes ago

Original-Research: FRIWO AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/26/2026 at 17:40, 1 hour 4 minutes ago

VALBIOTIS SA: Valbiotis ouvre un nouveau relais de croissance avec la commercialisation de l’ensemble de ses gammes sur Amazon France

View all EQS

Published on 10/26/2026 at 18:11, 33 minutes ago

Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 33 minutes ago

Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 59 minutes ago

Weekly share buyback
Published on 10/26/2026 at 17:45, 59 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 59 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.

View all LES ECHOS COMFI WIRE

News